Chinese Expert Consensus Workshop Report: Guideline for permanent iodine-125 seed implantation of primary and metastatic lung tumors.
Fujun ZhangJunjie WangJinhe GuoYuliang LiXuequan HuangZhiyu GuanGuangyan LeiJuan WangXin YeXiaogang ZhaoJing WangRuoyu WangBin LiuPublished in: Thoracic cancer (2018)
Surgery remains the first choice of cure for early stage lung cancer. However, many patients are diagnosed at advanced stage, and thus miss the opportunity to undergo surgery. As such patients derive limited benefits from chemotherapy or radiotherapy, alternatives focusing on local control have emerged, including iodine-125 seed implantation. The Interstitial Brachytherapy Society, Committee of Minimally Invasive Therapy in Oncology, Chinese Anti-Cancer Association organized a group of multidisciplinary experts to develop guidelines for this treatment modality. These guidelines aim to standardize iodine-125 seed implantation procedures, inclusion criteria, and outcome assessment to prevent and manage procedure-related complications.
Keyphrases
- minimally invasive
- early stage
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- squamous cell carcinoma
- locally advanced
- prognostic factors
- radiation therapy
- small cell lung cancer
- high dose
- stem cells
- low dose
- patient reported outcomes
- clinical practice
- atrial fibrillation
- dual energy
- risk factors
- rectal cancer
- contrast enhanced
- replacement therapy